Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
758 | 3011 | 42.4 | 86% |
Classes in level above (level 2) |
ID, lev. above |
Publications | Label for level above |
---|---|---|
1265 | 8379 | CHRONIC LYMPHOCYTIC LEUKEMIA//HAIRY CELL LEUKEMIA//CLL |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | CHRONIC LYMPHOCYTIC LEUKEMIA | Author keyword | 198 | 29% | 19% | 587 |
2 | CLL | Author keyword | 129 | 32% | 11% | 337 |
3 | B CLL | Author keyword | 94 | 41% | 6% | 181 |
4 | ZAP 70 | Author keyword | 83 | 50% | 4% | 120 |
5 | CHRONIC LYMPHOCYTIC LEUKAEMIA | Author keyword | 60 | 29% | 6% | 173 |
6 | MONOCLONAL B CELL LYMPHOCYTOSIS | Author keyword | 56 | 74% | 1% | 42 |
7 | TRISOMY 12 | Author keyword | 46 | 60% | 2% | 50 |
8 | HCT UNIT | Address | 38 | 62% | 1% | 40 |
9 | CLIN EXPT ONCOHEMATOL UNIT | Address | 25 | 62% | 1% | 26 |
10 | IGVH | Author keyword | 22 | 81% | 0% | 13 |
Web of Science journal categories |
Author Key Words |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | CHRONIC LYMPHOCYTIC LEUKEMIA | 198 | 29% | 19% | 587 | Search CHRONIC+LYMPHOCYTIC+LEUKEMIA | Search CHRONIC+LYMPHOCYTIC+LEUKEMIA |
2 | CLL | 129 | 32% | 11% | 337 | Search CLL | Search CLL |
3 | B CLL | 94 | 41% | 6% | 181 | Search B+CLL | Search B+CLL |
4 | ZAP 70 | 83 | 50% | 4% | 120 | Search ZAP+70 | Search ZAP+70 |
5 | CHRONIC LYMPHOCYTIC LEUKAEMIA | 60 | 29% | 6% | 173 | Search CHRONIC+LYMPHOCYTIC+LEUKAEMIA | Search CHRONIC+LYMPHOCYTIC+LEUKAEMIA |
6 | MONOCLONAL B CELL LYMPHOCYTOSIS | 56 | 74% | 1% | 42 | Search MONOCLONAL+B+CELL+LYMPHOCYTOSIS | Search MONOCLONAL+B+CELL+LYMPHOCYTOSIS |
7 | TRISOMY 12 | 46 | 60% | 2% | 50 | Search TRISOMY+12 | Search TRISOMY+12 |
8 | IGVH | 22 | 81% | 0% | 13 | Search IGVH | Search IGVH |
9 | B CELL CHRONIC LYMPHOCYTIC LEUKAEMIA | 20 | 54% | 1% | 26 | Search B+CELL+CHRONIC+LYMPHOCYTIC+LEUKAEMIA | Search B+CELL+CHRONIC+LYMPHOCYTIC+LEUKAEMIA |
10 | CD38 | 17 | 17% | 3% | 90 | Search CD38 | Search CD38 |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | CD38 EXPRESSION | 632 | 69% | 18% | 535 |
2 | CLL | 328 | 55% | 14% | 412 |
3 | ZAP 70 EXPRESSION | 316 | 72% | 8% | 247 |
4 | GENOMIC ABERRATIONS | 288 | 66% | 9% | 265 |
5 | VARIABLE REGION MUTATIONS | 239 | 77% | 5% | 161 |
6 | GENE MUTATION STATUS | 207 | 71% | 6% | 167 |
7 | GENE MUTATIONAL STATUS | 120 | 89% | 2% | 55 |
8 | MULTIVARIATE SURVIVAL ANALYSIS | 89 | 62% | 3% | 91 |
9 | V H GENES | 88 | 40% | 6% | 170 |
10 | MUTATION STATUS | 77 | 36% | 6% | 174 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
Guidelines for the diagnosis and treatment of chronic lymphocytic leukemia: a report from the International Workshop on Chronic Lymphocytic Leukemia updating the National Cancer Institute-Working Group 1996 guidelines | 2008 | 939 | 63 | 43% |
Mechanisms of disease: Chronic lymphocytic leukemia | 2005 | 763 | 100 | 64% |
From pathogenesis to treatment of chronic lymphocytic leukaemia | 2010 | 197 | 147 | 69% |
Role of miR-15/16 in CLL | 2015 | 4 | 44 | 43% |
The microenvironment in chronic lymphocytic leukemia (CLL) and other B cell malignancies: Insight into disease biology and new targeted therapies | 2014 | 27 | 179 | 39% |
Monoclonal B-cell lymphocytosis (MBL): biology, natural history and clinical management | 2010 | 85 | 39 | 72% |
Diagnostic criteria for monoclonal B-cell lymphocytosis | 2005 | 191 | 28 | 75% |
ERIC recommendations on TP53 mutation analysis in chronic lymphocytic leukemia | 2012 | 51 | 27 | 70% |
Emerging role of kinase-targeted strategies in chronic lymphocytic leukemia | 2012 | 58 | 68 | 54% |
B cell receptor signaling in chronic lymphocytic leukemia | 2013 | 26 | 115 | 57% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | HCT UNIT | 38 | 62% | 1.3% | 40 |
2 | CLIN EXPT ONCOHEMATOL UNIT | 25 | 62% | 0.9% | 26 |
3 | FLOW IMAGE CYTOMETRY SECT | 15 | 82% | 0.3% | 9 |
4 | CELL NEOPLASIA B | 12 | 58% | 0.5% | 14 |
5 | MAGGIORE GEN HOSP | 12 | 86% | 0.2% | 6 |
6 | SS MOL DIAGNOST | 11 | 100% | 0.2% | 6 |
7 | CLL CONSORTIUM | 11 | 69% | 0.3% | 9 |
8 | CLIN UNIT LYMPHOID MALIGNANCIES | 10 | 73% | 0.3% | 8 |
9 | ONCOL MED C | 9 | 67% | 0.3% | 8 |
10 | COOPERAT UNIT MECH LEUKEMOGENESIS | 7 | 56% | 0.3% | 9 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000233135 | FLUDARABINE//CHRONIC LYMPHOCYTIC LEUKEMIA//CLADRIBINE |
2 | 0.0000147291 | RICHTERS SYNDROME//RICHTER SYNDROME//COMPOSITE LYMPHOMA |
3 | 0.0000117600 | T LYMPHOCYTE IMMUNOLOGY//CLIN HOSP O NOVOSEL MED MED//MITOGEN INDUCED CELLULAR CYTOTOXICITY |
4 | 0.0000096364 | T CELL PROLYMPHOCYTIC LEUKEMIA//T PLL//TCL1 |
5 | 0.0000078440 | MANTLE CELL LYMPHOMA//T1114//BCL 1 |
6 | 0.0000067319 | SPLENIC MARGINAL ZONE LYMPHOMA//NODAL MARGINAL ZONE LYMPHOMA//MONOCYTOID B CELL LYMPHOMA |
7 | 0.0000060629 | FOLLICULAR LYMPHOMA//T1418//IN SITU FOLLICULAR LYMPHOMA |
8 | 0.0000057974 | ADAPHOSTIN//BONE MARROW MICROVESSEL DENSITY//PEDIAT PEDIAT ONCOL HEMATOL |
9 | 0.0000048473 | SYK//SPLEEN TYROSINE KINASE//R788 |
10 | 0.0000044016 | HAIRY CELL LEUKEMIA//HAIRY CELL LEUKAEMIA//HAIRY CELL LEUKEMIA VARIANT |